Ferroptosis induction via targeting metabolic alterations in head and neck cancer

被引:8
|
作者
Lee, Jaewang [1 ,2 ]
Roh, Jong-Lyel [1 ,2 ]
机构
[1] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, Gyeonggi Do, South Korea
[2] CHA Univ, Gen Grad Sch, Dept Biomed Sci, Seongnam, South Korea
基金
新加坡国家研究基金会;
关键词
Metabolism; Mitochondria; Ferroptosis; Lipid peroxidation; Head and neck cancer; SQUAMOUS-CELL CARCINOMA; CISPLATIN-RESISTANT HEAD; NASOPHARYNGEAL CARCINOMA; LIPID DROPLETS; TUMOR-GROWTH; INHIBITION; IRON; DEATH; CELECOXIB; METASTASIS;
D O I
10.1016/j.critrevonc.2022.103887
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ferroptosis is a newly regulated cell death induced by the accumulation of iron-mediated lipid peroxidation. The alteration of cancer metabolism may contribute to proliferation, metastasis, and treatment resistance in human cancers, implicating the sensitivity to ferroptosis induction. Altered metabolism in cancer cells regulates oxidative stresses and changes metabolism intermediates, contributing to their deregulated growth and prolif-eration. Cancer metabolic changes toward the elevation of cellular free iron and polyunsaturated fatty acids sensitize cancer cells to lipid peroxidation toxicity tightly linked to ferroptosis. The altered metabolism in cancers can be served as a promising target to reverse cancer therapeutic resistance by ferroptosis induction to selectively kill cancer cells while sparing normal cells. The role of mitochondria and lipid metabolism in inducing ferroptosis in head and neck cancer (HNC) has been elucidated in previous studies. Ferroptosis is receiving attention in cancer research as treating cancers altering cellular metabolism and refractory from conventional therapies. More in-depth studies are needed to develop highly therapeutic drugs and practical methods to induce ferroptosis in diverse cancer cells and tumor microenvironments effectively. Therefore, this review intends to understand the altered metabolism and find new therapeutic possibilities using ferroptosis in HNC.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Targeting EGFR resistance networks in head and neck cancer
    Ratushny, Vladimir
    Astsaturov, Igor
    Burtness, Barbara A.
    Golemis, Erica A.
    Silverman, Joshua S.
    CELLULAR SIGNALLING, 2009, 21 (08) : 1255 - 1268
  • [42] Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer
    Schniewind, Inaki
    Besso, Maria Jose
    Klicker, Sebastian
    Schwarz, Franziska Maria
    Hadiwikarta, Wahyu Wijaya
    Richter, Susan
    Lock, Steffen
    Linge, Annett
    Krause, Mechthild
    Dubrovska, Anna
    Baumann, Michael
    Kurth, Ina
    Peitzsch, Claudia
    CANCERS, 2024, 16 (04)
  • [43] Targeting Head and Neck Cancer by Vaccination
    Wang, Chuan
    Dickie, James
    Sutavani, Ruhcha V.
    Pointer, Catherine
    Thomas, Gareth J.
    Savelyeva, Natalia
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [44] Targeting angiogenesis in head and neck cancer
    Saba, Nabil F.
    Shin, Dong M.
    Khuri, Fadlo R.
    CURRENT CANCER DRUG TARGETS, 2007, 7 (07) : 643 - 649
  • [45] Targeting the future in head and neck cancer
    Brizel, David M.
    LANCET ONCOLOGY, 2009, 10 (03) : 204 - 205
  • [46] microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer
    Obayashi, Mariko
    Yoshida, Maki
    Tsunematsu, Takaaki
    Ogawa, Ikuko
    Sasahira, Tomonori
    Kuniyasu, Hiroki
    Imoto, Issei
    Abiko, Yoshimitsu
    Xu, Dan
    Fukunaga, Saori
    Tahara, Hidetoshi
    Kudo, Yasusei
    Nagao, Toshitaka
    Takata, Takashi
    ONCOTARGET, 2016, 7 (07) : 8223 - 8239
  • [47] Induction chemotherapy in head and neck cancer: a new paradigm
    Pointreau, Yoann
    Atean, Ibrahim
    Fayette, Jerome
    Calais, Gilles
    Lefebvre, Jean Louis
    ANTI-CANCER DRUGS, 2011, 22 (07) : 613 - 620
  • [48] Role of induction chemotherapy in head and neck cancer: Cons
    Huguet, F.
    Schick, U.
    Pointreau, Y.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 510 - 514
  • [49] Combination of mTOR and EGFR targeting in an orthotopic xenograft model of head and neck cancer
    Bozec, Alexandre
    Ebran, Nathalie
    Radosevic-Robin, Nina
    Sudaka, Anne
    Monteverde, Martino
    Toussan, Nicolas
    Etienne-Grimaldi, Marie-Christine
    Lo Nigro, Cristiana
    Merlano, Marco
    Penault-Llorca, Frederique
    Milano, Gerard
    LARYNGOSCOPE, 2016, 126 (04) : E156 - E163
  • [50] Research progress on ferroptosis in head and neck squamous cell carcinoma
    Qiu, Yi
    Su, Yuyuan
    Sai, Wenli
    Feng, Guijuan
    JOURNAL OF MOLECULAR HISTOLOGY, 2025, 56 (02)